??The United States Dana Farber cancer center-the researchers report a new vaccine, the vaccine can help with common type of lung cancer patients.In the advanced non-small-cell lung cancer (NSCLC) patients, the vaccine can produce an immune response.
??
??The study said the physicians, have confirmed that NSCLC cell can in some patients the body produces antineoplastic immune response, so the researchers decided to further study.They use 34 patients to illuminate the NSCLC cell back note to their bodies.There are nine patients because of terminal illness progress and exit the research, but in the rest of the 25 patients had 18 example shows positive reaction.There are 2 patients had already received the vaccine in the resection of the tumor, they accept vaccination disease-free survival after three years.
??
??According to the different conditions the vaccine can injection in the arms, legs, and and abdomen.These participant?s in the study patients who receive 1 week 1 times for three weeks, the injection, then every other week 1 times, until the vaccine injection in the exit the study or the patients.
??
??Use this cancer vaccine ideas from melanoma.The doctors say these in melanoma vaccine research on simulation research of before, and the results of melanoma patients after exposure of the injection of autologous homologous melanoma cells, a surprising vaccine similar antitumor reaction.
Source: http://treatments-for-lung-cancer.com/Lung-cancer-cell-lung-cancer-vaccine-may-treatment-1988/
nasdaq kids games chi charles schwab spy wall street wall street
No comments:
Post a Comment